{
    "laboratory_examinations": [
        {
            "procedure_name": "Hemoglobin A1c (HbA1c)",
            "date": "Not specified",
            "findings": "HbA1c was 6.7%, increased from 6.4% at the last visit.",
            "changes_over_time": "Increased from 6.4% to 6.7% over 3 months."
        },
        {
            "procedure_name": "Fasting glucose with C-peptide, 2-hour post-prandial urinary C-peptide to creatinine ratio (UCPCR), and antibody tests (GADA, IA-2A, ZnT8)",
            "date": "Not specified",
            "findings": "Three negative antibody tests (GADA, IA-2A, ZnT8).",
            "changes_over_time": "Not specified."
        },
        {
            "procedure_name": "Hemoglobin A1c (HbA1c)",
            "date": "Two years later",
            "findings": "HbA1c rose to 8.7%.",
            "changes_over_time": "Increased from <7.0% to 8.7% over two years."
        },
        {
            "procedure_name": "C-peptide test",
            "date": "Not specified",
            "findings": "C-peptide of 1.2 ng/mL (reference 0.8 - 3.2 ng/mL).",
            "changes_over_time": "Not specified."
        },
        {
            "procedure_name": "Hemoglobin A1c (HbA1c)",
            "date": "6 months after starting GLP-1 RA treatment",
            "findings": "HbA1c improved to 6.2%.",
            "changes_over_time": "Improved from 8.7% to 6.2% after 6 months of GLP-1 RA treatment."
        },
        {
            "procedure_name": "Lipid panel",
            "date": "Not specified",
            "findings": "Total cholesterol 137 mg/dL, HDL 25 mg/dL, LDL 76 mg/dL, triglycerides 182 mg/dL.",
            "changes_over_time": "Not specified."
        },
        {
            "procedure_name": "Urine albumin:creatinine ratio",
            "date": "Not specified",
            "findings": "Urine albumin:creatinine ratio was 17 mg/g.",
            "changes_over_time": "Not specified."
        }
    ]
}